JUN 18, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Tramadol Hydrochloride (REMS)
U.S. Food and Drug Administration
FDA supplemental approval of tramadol hydrochloride tablet formulation under REMS framework; establishes risk mitigation requirements but does not report clinical efficacy or comparative trial outcomes.
Reported
Dosage formTablet, oral, 50 mg
Approval date2026-06-18